S&P 500 7,475.00 â–ŧ 25.58 (-0.34%) DOW 51,696.81 ▲ 132.11 (+0.26%) NASDAQ 26,183.01 â–ŧ 334.92 (-1.26%) US Markets Open â€ĸ 03:52 PM ET

PFSA

Profusa, Inc.

Price Chart
Latest Quote

$0.16

-0.02 (-12.44%)
Current Price
Previous Close $0.18
Open $0.16
Day High $0.16
Day Low $0.15
Volume 2,212,412
Fetched: 2026-06-22T19:52:21
Stock Information
Shares Outstanding 4.66M
Total Debt $12.54M
Cash Equivalents $375K
Net Income $-36.56M
Sector Healthcare
Industry Medical Devices
Market Cap $738K
EPS (TTM) $-15.42
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$13.01M
Income$-36.56M
Book/sh$-11.85
Cash/sh$0.08
Financial Ratios
Quick Ratio0.01
Current Ratio0.02
Returns & Margins
ROA-923.19%
Ownership
Insider Ownership3.49%
Institutional Ownership1.57%
Insider & Institutional transactions data not available
Valuation Ratios
P/B-0.01
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.29
SMA50$0.45
SMA200$8.60
RSI25.56
ATR0.0382
Shares Float4.55M
Short Float6.23%
Short Ratio0.96
Volatility0.32
Rel Volume0.94
Performance History
Week-29.29%
Month-61.18%
Quarter-69.94%
6 Months-98.03%
YTD-97.89%
10 Years-99.92%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-22 $0.16 2,212,412
2026-06-18 $0.18 15,128,800
2026-06-17 $0.25 23,175,900
2026-06-16 $0.22 694,700
2026-06-15 $0.24 523,500
2026-06-12 $0.22 1,025,700
2026-06-11 $0.27 953,800
2026-06-10 $0.25 325,300
2026-06-09 $0.28 288,700
2026-06-08 $0.29 346,000
2026-06-05 $0.27 277,600
2026-06-04 $0.29 207,000
2026-06-03 $0.32 185,300
2026-06-02 $0.32 189,300
2026-06-01 $0.34 200,000
2026-05-29 $0.35 185,600
2026-05-28 $0.36 627,300
2026-05-27 $0.37 131,000
2026-05-26 $0.37 147,000
2026-05-22 $0.38 123,100
About Profusa, Inc.

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $2,521,000 $4,424,000 $4,283,000 $6,270,000
Total Expenses $27,706,000 $4,500,000 $6,070,000 $9,443,000
Other Income Expense $-3,022,000 $-306,000 $72,000 $-4,504,000
Other Non Operating Income Expenses $-3,362,000 $-306,000 $72,000 $-3,000
Net Non Operating Interest Income Expense $-5,095,000 $-4,424,000 $-4,283,000 $-6,270,000
Total Other Finance Cost $2,574,000 - - -
Interest Expense Non Operating $2,521,000 $4,424,000 $4,283,000 $6,270,000
Operating Expense $27,706,000 $4,500,000 $6,070,000 $9,443,000
General And Administrative Expense $24,902,000 $2,992,000 $4,079,000 $5,244,000
Other Operating Expenses - $-100,000 $-45,000 -
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Net Interest Income $-5,095,000 $-4,424,000 $-4,283,000 $-6,270,000
Normalized Income $-36,163,000 $-9,230,000 $-10,281,000 $-15,716,000
Net Income From Continuing And Discontinued Operation $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Total Operating Income As Reported $-27,706,000 $-4,500,000 $-6,070,000 $-11,140,000
Net Income Common Stockholders $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Net Income $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Net Income Including Noncontrolling Interests $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Net Income Continuous Operations $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Pretax Income $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Operating Income $-27,706,000 $-4,500,000 $-6,070,000 $-9,443,000
Special Income Charges - - - $-6,532,000
Per Share
Diluted EPS $-107.01 $-21.11 $-23.52 $-46.24
Basic EPS $-107.01 $-21.11 $-23.52 $-46.24
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-33,642,000 $-4,806,000 $-5,998,000 $-8,722,000
Total Unusual Items $340,000 - - $-4,501,000
Total Unusual Items Excluding Goodwill $340,000 - - $-4,501,000
EBITDA (Bullshit earnings) $-33,302,000 $-4,806,000 $-5,998,000 $-13,223,000
EBIT $-33,302,000 $-4,806,000 $-5,998,000 $-13,947,000
Diluted Average Shares $334,762 $437,185 $437,185 $437,185
Basic Average Shares $334,762 $437,185 $437,185 $437,185
Diluted NI Availto Com Stockholders $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Gain On Sale Of Security $340,000 - - $2,031,000
Research And Development $2,804,000 $1,608,000 $2,036,000 $4,199,000
Selling General And Administration $24,902,000 $2,992,000 $4,079,000 $5,244,000
Other Gand A $24,902,000 $2,992,000 $4,079,000 $5,244,000
Reconciled Depreciation - - - $724,000
Other Special Charges - - - $6,532,000
Fetched: 2026-06-22
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-26,658,000 $-119,205,000 $-109,996,000 $-99,771,000
Total Assets $3,775,000 $3,073,000 $1,893,000 $1,031,000
Total Non Current Assets $11,000 $2,813,000 $1,560,000 $871,000
Other Non Current Assets $3,000 $56,000 $31,000 $30,000
Non Current Deferred Assets $0 $2,757,000 $1,527,000 $841,000
Current Assets $3,764,000 $260,000 $333,000 $160,000
Other Current Assets $1,445,000 - - $82,000
Prepaid Assets $541,000 $69,000 $146,000 -
Cash Cash Equivalents And Short Term Investments $1,778,000 $191,000 $142,000 $78,000
Cash And Cash Equivalents $1,778,000 $191,000 $142,000 $78,000
Cash Financial $1,778,000 $191,000 $142,000 $78,000
Receivables - $0 $45,000 $0
Other Receivables - - $45,000 -
Accounts Receivable - - - $0
Debt
Net Debt $13,037,000 $48,016,000 $40,254,000 $30,954,000
Total Debt $14,815,000 $48,207,000 $40,396,000 $31,032,000
Long Term Debt And Capital Lease Obligation $7,877,000 - - $0
Long Term Debt $7,877,000 - - -
Current Debt And Capital Lease Obligation $6,938,000 $48,207,000 $40,396,000 $31,032,000
Current Debt $6,938,000 $48,207,000 $40,396,000 $31,032,000
Other Current Borrowings $5,592,000 $47,297,000 $39,547,000 $30,456,000
Liabilities
Total Liabilities Net Minority Interest $30,433,000 $122,278,000 $111,889,000 $100,802,000
Total Non Current Liabilities Net Minority Interest $8,175,000 $65,149,000 $65,149,000 $65,149,000
Derivative Product Liabilities $298,000 $0 - -
Current Liabilities $22,258,000 $57,129,000 $46,740,000 $35,653,000
Current Notes Payable $1,346,000 $910,000 $849,000 $576,000
Payables And Accrued Expenses $11,254,000 $5,450,000 $4,384,000 $4,037,000
Payables $9,339,000 $4,954,000 $3,993,000 $3,428,000
Total Tax Payable $1,953,000 $0 - -
Accounts Payable $7,345,000 $4,954,000 $3,993,000 $3,428,000
Other Current Liabilities - - - -
Equity
Common Stock Equity $-26,658,000 $-119,205,000 $-109,996,000 $-99,771,000
Total Equity Gross Minority Interest $-26,658,000 $-119,205,000 $-109,996,000 $-99,771,000
Stockholders Equity $-26,658,000 $-119,205,000 $-109,996,000 $-99,771,000
Retained Earnings $-160,781,000 $-124,958,000 $-115,728,000 $-105,447,000
Preferred Securities Outside Stock Equity $0 $65,149,000 $65,149,000 $65,149,000
Other
Ordinary Shares Number $1,232,051 $1,232,051 $437,185 $437,185
Share Issued $1,232,051 $1,232,051 $437,185 $437,185
Tangible Book Value $-26,658,000 $-119,205,000 $-109,996,000 $-99,771,000
Invested Capital $-11,843,000 $-70,998,000 $-69,600,000 $-68,739,000
Working Capital $-18,494,000 $-56,869,000 $-46,407,000 $-35,493,000
Total Capitalization $-18,781,000 $-119,205,000 $-109,996,000 $-99,771,000
Additional Paid In Capital $134,123,000 $5,753,000 $5,732,000 $5,676,000
Capital Stock $0 $0 $0 $0
Common Stock $0 $0 $0 $0
Pensionand Other Post Retirement Benefit Plans Current $4,066,000 $3,472,000 $1,960,000 $584,000
Current Accrued Expenses $1,915,000 $496,000 $391,000 $609,000
Dueto Related Parties Current $41,000 $0 - -
Net PPE $8,000 $0 $2,000 $0
Gross PPE - $0 $2,000 $821,000
Other Properties - - $2,000 $41,000
Capital Lease Obligations - - - $0
Long Term Capital Lease Obligation - - - $0
Current Capital Lease Obligation - - - $0
Accumulated Depreciation - - - $-821,000
Leases - - - $0
Machinery Furniture Equipment - - - $780,000
Properties - - - $0
Fetched: 2026-06-22
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-16,256,000 $-2,066,000 $-4,404,000 $-7,702,000
Operating Activities
Operating Cash Flow $-16,248,000 $-2,066,000 $-4,402,000 $-7,702,000
Cash Flow From Continuing Operating Activities $-16,248,000 $-2,066,000 $-4,402,000 $-7,702,000
Operating Gains Losses $-895,000 $2,000 - $6,780,000
Investing Activities
Capital Expenditure $-8,000 - $-2,000 -
Investing Cash Flow $-2,008,000 $0 $-2,000 -
Cash Flow From Continuing Investing Activities $-2,008,000 $0 $-2,000 -
Financing Activities
Financing Cash Flow $19,843,000 $2,115,000 $4,468,000 $6,924,000
Cash Flow From Continuing Financing Activities $19,843,000 $2,115,000 $4,468,000 $6,924,000
Net Other Financing Charges $10,278,000 $-961,000 $-614,000 $-789,000
Other
Repayment Of Debt $-2,885,000 $-150,000 $-151,000 $-358,000
Issuance Of Debt $12,450,000 $3,226,000 $5,210,000 $8,054,000
End Cash Position $1,778,000 $191,000 $142,000 $78,000
Beginning Cash Position $191,000 $142,000 $78,000 $856,000
Changes In Cash $1,587,000 $49,000 $64,000 $-778,000
Net Issuance Payments Of Debt $9,565,000 $3,076,000 $5,059,000 $7,696,000
Net Short Term Debt Issuance $9,565,000 $3,076,000 $5,059,000 $7,696,000
Short Term Debt Payments $-2,885,000 $-150,000 $-151,000 $-358,000
Short Term Debt Issuance $12,450,000 $3,226,000 $5,210,000 $8,054,000
Net Investment Purchase And Sale $-2,000,000 $0 - -
Purchase Of Investment $-2,000,000 $0 - -
Net PPE Purchase And Sale $-8,000 $0 $-2,000 -
Purchase Of PPE $-8,000 $0 $-2,000 -
Change In Working Capital $4,346,000 $2,406,000 $1,541,000 $909,000
Change In Other Current Assets $53,000 $-25,000 $-1,000 $-25,000
Change In Payables And Accrued Expense $4,082,000 $2,309,000 $1,651,000 $1,340,000
Change In Accrued Expense $522,000 $1,664,000 $1,118,000 $634,000
Change In Payable $3,560,000 $645,000 $533,000 $706,000
Change In Account Payable $3,560,000 $645,000 $533,000 $706,000
Change In Prepaid Assets $211,000 $77,000 $-64,000 $-18,000
Change In Receivables $0 $45,000 $-45,000 $38,000
Other Non Cash Items $14,678,000 $4,735,000 $4,305,000 $3,991,000
Stock Based Compensation $891,000 $21,000 $33,000 $111,000
Unrealized Gain Loss On Investment Securities $555,000 $0 - -
Gain Loss On Investment Securities $-895,000 - - $-2,031,000
Gain Loss On Sale Of PPE $0 $2,000 $0 -
Net Income From Continuing Operations $-35,823,000 $-9,230,000 $-10,281,000 $-20,217,000
Proceeds From Stock Option Exercised - $0 $23,000 $17,000
Net Long Term Debt Issuance - - - $0
Long Term Debt Issuance - - - $0
Change In Other Current Liabilities - - - $-426,000
Depreciation Amortization Depletion - - - $724,000
Depreciation And Amortization - - - $724,000
Depreciation - - - $724,000
Fetched: 2026-06-22